$1.13
-0.02-1.74%
At close: -
$1.13
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Ovid Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ovid Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $0.12 | $-0.22 | 154.6 % |
Mar 2024 | 2024-05-14 | $-0.17 | $-0.22 | 22.7 % |
Dec 2023 | 2024-03-08 | $-0.22 | $-0.05 | -340.0 % |
Sep 2023 | 2023-11-03 | $-0.16 | $-0.19 | 15.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $169.00K | $70.00K | 141.4 % |
Mar 2024 | 2024-05-14 | $148.00K | $60.00K | 146.7 % |
Sep 2023 | 2023-11-03 | $108.97K | $50.00K | 117.9 % |
Jun 2023 | 2023-08-04 | $75.00K | $50.00K | 50.0 % |
Ovid Therapeutics (OVID) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $0.12, which beat the estimate of $-0.22.
The Actual Revenue was $169K, which beat the estimate of $70K.
Browse earnings estimates, EPS, and revenue on all stocks.